Sencure develops chips that helps measure electrophysiological parameters on the human body in innovative ways.
Sencure has raised $4.3M in total funding. The most recent round was Series B. The last funding was announced in March 2025.
Sencure's investors include Cottonwood Technology Fund, NV NOM, 819 Capital Partners, Lumana Invest, Bluegrass Ventures.
Sencure is headquartered in Roden, The Netherlands.
Sencure develops chips that helps measure electrophysiological parameters on the human body in innovative ways.
Sencure is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sencure — Funding & Investors." VCBacked, March 11, 2025, https://www.vcbacked.co/company/sencure. Accessed July 31, 2026.
VCBacked. (2025). Sencure — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/sencure
{{cite web |title=Sencure — Funding & Investors |url=https://www.vcbacked.co/company/sencure |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated